Iodine iolopride (123I)

Iodine iolopride (123I) is a radiopharmaceutical used in nuclear medicine imaging. It is used to diagnose cerebral perfusion disorders and evaluate the functionality of the brain, as well as to aid in the diagnosis of neurodegenerative diseases. It is a derivative of propionic acid and is labeled with the radioactive isotope iodine-123. 123I iolopride binds to the dopamine D2 receptors in the brain, which allows for imaging of these receptors to detect any abnormalities. It is typically administered intravenously as a single bolus, and the imaging is usually done one to four hours after injection.

Iodine iolopride (123I), also known by the trade name Iobenguan (not to be confused with Iobenguane, a different radiopharmaceutical agent), is a medication used in nuclear medicine for imaging the nervous system, particularly the intestines [Wikipedia, Iodine iolopride (123I)].

Here's a breakdown of its key features:

Function:

• It combines two parts:
  • Iodine-123 (123I): A radioactive isotope of iodine with a short half-life (around 13 hours) that emits gamma rays for imaging purposes.
  • Iolopride: A molecule that mimics a natural neurotransmitter called cholecystokinin (CCK). Iolopride binds to specific receptors for CCK in the nervous system, particularly those concentrated in the gastrointestinal tract.

How it Works:

1. Iodine iolopride (123I) is injected intravenously.
2. Iolopride travels through the bloodstream and binds to CCK receptors in the intestines.
3. Areas with higher concentrations of CCK receptors, such as inflamed tissues or tumors, will take up more of the radioactive agent.
4. The radioactive iodine-123 emits gamma rays which are then detected by a special gamma camera.
5. A computer translates the gamma ray information into an image, allowing visualization of CCK receptor activity in the intestines.

Applications:

• Iodine iolopride (123I) is primarily used in a diagnostic imaging technique called single-photon emission computed tomography (SPECT) for the intestines.
• A SPECT scan with Iodine iolopride (123I) can be useful for:
  • Identifying inflammation in the gastrointestinal tract, such as inflammatory bowel disease (IBD).
  • Locating tumors or neuroendocrine growths in the intestines.

Important Considerations:

• Due to the radioactive nature of iodine-123, there are limitations to its use:
  • Pregnant and breastfeeding women are typically excluded due to potential risks to the developing baby.
  • It may not be suitable for everyone, especially those with kidney problems, allergies to iodine, or certain heart conditions.
• There can be potential side effects associated with the procedure, such as headache, dizziness, or nausea. However, these are usually mild and temporary.